PSIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.944000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.169400E-01
Normal-vs-Stage2
3.706200E-01
Normal-vs-Stage3
2.765400E-01
Normal-vs-Stage4
4.137200E-01
Stage1-vs-Stage2
3.010000E-01
Stage1-vs-Stage3
1.088780E-01
Stage1-vs-Stage4
5.953200E-01
Stage2-vs-Stage3
3.380200E-01
Stage2-vs-Stage4
7.553200E-01
Stage3-vs-Stage4
6.803600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.032000E-01
Normal-vs-AfricanAmerican
2.273000E-01
Normal-vs-Asian
2.703200E-01
Caucasian-vs-AfricanAmerican
8.861800E-01
Caucasian-vs-Asian
6.715500E-03
AfricanAmerican-vs-Asian
6.948500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.847400E-01
Normal-vs-Female
4.096600E-01
Male-vs-Female
5.622400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.768600E-01
Normal-vs-Age(41-60Yrs)
4.610400E-01
Normal-vs-Age(61-80Yrs)
3.762200E-01
Normal-vs-Age(81-100Yrs)
3.076200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.056800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.220000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.734000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.852200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.875800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.478850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.148200E-01
Normal-vs-Daily Drinker
4.553600E-02
Normal-vs-Weekly Drinker
9.589600E-02
Normal-vs-Occasional Drinker
1.667030E-01
Normal-vs-Social Drinker
2.063400E-01
Non Drinker-vs-Daily Drinker
7.019200E-01
Non Drinker-vs-Weekly Drinker
3.625800E-01
Non Drinker-vs-Occasional Drinker
1.484370E-01
Non Drinker-vs-Social Drinker
1.154960E-01
Daily Drinker-vs-Weekly Drinker
6.245600E-01
Daily Drinker-vs-Occasional Drinker
3.205800E-01
Daily Drinker-vs-Social Drinker
2.431600E-01
Weekly Drinker-vs-Occasional Drinker
6.473800E-01
Weekly Drinker-vs-Social Drinker
5.211400E-01
Occasional Drinker-vs-Social Drinker
8.474200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.158800E-01
Normal-vs-Grade 2
8.003600E-01
Normal-vs-Grade 3
7.963000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.282200E-01
Grade 1-vs-Grade 3
1.251190E-01
Grade 1-vs-Grade 4
8.158800E-01
Grade 2-vs-Grade 3
9.063400E-01
Grade 2-vs-Grade 4
8.003600E-01
Grade 3-vs-Grade 4
7.963000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.936600E-01
Normal-vs-NonDiabetic
3.716000E-01
Diabetic-vs-NonDiabetic
6.860000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.038800E-01
Normal-vs-NoPancreatitis
3.838000E-01
Pancreatitis-vs-NoPancreatitis
5.330400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.047200E-01
Normal-vs-N1
3.610200E-01
N0-vs-N1
4.180500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.608000E-01
Normal-vs-TP53-NonMutant
2.527400E-01
TP53-Mutant-vs-TP53-NonMutant
5.883700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
